| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 75466 |
Mal-amido-PEG8-val-gly-PAB-OH（CAS: 2353409-52-4） |
109 |
WYQ |
2024-12-19 |
| 75467 |
cas:160854-54-6，4-succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene，ADC定制 |
91 |
wyh |
2024-12-19 |
| 75468 |
cas:2504147-59-3 MC (C5)-Val-Cit |
129 |
zyl |
2024-12-19 |
| 75469 |
Boc-PEG4-Val-Ala-PAB，可降解的ADC连接体 |
140 |
WYQ |
2024-12-19 |
| 75470 |
cas:2058075-34-4，DGN549-C ， ADC试剂 |
87 |
kx |
2024-12-19 |
| 75471 |
CAS: 1639939-40-4，Mal-Val-Ala-PAB-PNP，马来酰亚胺-VAL-ALA-PAB-PNP |
125 |
WYQ |
2024-12-19 |
| 75472 |
Fmoc-VC-PAB-Duocarmycin SA， ADC试剂 |
99 |
kx |
2024-12-19 |
| 75473 |
Mal-PEG4-Val-Ala-PAB，可降解的ADC（抗体偶联药物）连接子 |
160 |
WYQ |
2024-12-19 |
| 75474 |
Mal-PEG1-Val-Cit-OH的介绍 |
126 |
zyl |
2024-12-19 |
| 75475 |
MC-vc-PAB-Monomethyl dolastatin10， ADC试剂 |
87 |
kx |
2024-12-19 |
| 75476 |
CAS: 1870916-87-2，Mal-Val-Ala-PAB，马来酰亚胺-缬氨酸-丙氨酸-对氨基苯甲酸 |
94 |
WYQ |
2024-12-19 |
| 75477 |
cas:2395887-69-9 Mal-PEG2-Val-Cit-PAB-PNP |
89 |
zyl |
2024-12-19 |
| 75478 |
SuO-Val-Cit-PAB-MMAE， ADC试剂 |
79 |
kx |
2024-12-19 |
| 75479 |
Mal-PEG4-Val-Ala-PAB-PNP的介绍 |
90 |
zyl |
2024-12-19 |
| 75480 |
CAS: 2348405-93-4，DBCO-PEG4-Val-Ala-PAB-PNP |
66 |
WYQ |
2024-12-19 |
| 75481 |
CAS: 2348405-92-3，DBCO-PEG4-Val-Ala-PAB |
81 |
WYQ |
2024-12-19 |
| 75482 |
cas:2112738-13-1 Mal-amido-PEG2-Val-Cit-PAB-PNP |
82 |
zyl |
2024-12-19 |
| 75483 |
Azido-PEG4-Val-Ala-PAB，分子式：C29H48N8O9 |
72 |
WYQ |
2024-12-19 |
| 75484 |
cas:2055896-86-9，MC-Val-Cit-PAB-tubulysin5a ， ADC试剂 |
90 |
kx |
2024-12-19 |
| 75485 |
Azido-PEG8-Val-Cit-PAB-PNP |
67 |
zyl |
2024-12-19 |
| 75486 |
cas:2055896-83-6，MC-Val-Cit-PAB-carfilzomib ， ADC试剂 |
112 |
kx |
2024-12-19 |
| 75487 |
MAL-di-EG-Val-Cit-PAB-MMAF， ADC试剂 |
84 |
kx |
2024-12-19 |
| 75488 |
cas:2353409-45-5 endo BCN-PEG3-VC-PFP Ester |
93 |
zyl |
2024-12-19 |
| 75489 |
Hydrazone-doxorubicin， ADC试剂 |
164 |
kx |
2024-12-19 |
| 75490 |
DBCO-C4-Val-Cit-PABC-PNP |
73 |
zyl |
2024-12-19 |
| 75491 |
cas:644981-35-1 Val-Cit-PAB-MMAE |
81 |
zyl |
2024-12-19 |
| 75492 |
cas:170908-81-3，DOTA-NHS ester ，1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸 1-(2,5-二氧代-1-吡咯烷基)酯 |
71 |
kx |
2024-12-19 |
| 75493 |
endo-BCN-PEG4-Val-Cit-PAB-MMAE的介绍 |
81 |
zyl |
2024-12-19 |
| 75494 |
cas:2259318-50-6，MA-PEG4-VA-PBD ， ADC试剂 |
96 |
kx |
2024-12-19 |
| 75495 |
CAS: 2259318-55-1 - DBCO-(PEG2-VC-PAB-MMAE)2 |
63 |
WYQ |
2024-12-19 |
| 75496 |
CAS: 2768446-73-5，DBCO-Val-Cit-PAB-MMAE |
76 |
WYQ |
2024-12-19 |
| 75497 |
MC-vc-PAB-C6-a-amanitin， ADC试剂 |
67 |
kx |
2024-12-19 |
| 75498 |
cas:663598-98-9，2,5-dioxopyrrolidin-1-yl 4-methyl-4-((5-nitropyridin-2-yl)disulfanyl)pentanoate，ADC定制 |
88 |
wyh |
2024-12-19 |
| 75499 |
cas:2873452-49-2 MC-EVCit-PAB-MMAE |
85 |
zyl |
2024-12-19 |
| 75500 |
2,5-dioxopyrrolidin-1-yl 3-methyl-3-(pyridin-2-yldisulfanyl)butanoate，ADC定制 |
92 |
wyh |
2024-12-19 |
| 75501 |
cas:159857-70-2 MC-Val-Cit-Doxorubicin |
117 |
zyl |
2024-12-19 |
| 75502 |
Gly3-vc-PAB-MMAE， ADC试剂 |
98 |
kx |
2024-12-19 |
| 75503 |
CAS: 1869126-64-6， Azido-PEG4-Val-Cit-PAB-MMAE |
80 |
WYQ |
2024-12-19 |
| 75504 |
cas:2353409-54-6 ， Mal-amido-PEG8-Val-Gly，ADC定制 |
102 |
wyh |
2024-12-19 |
| 75505 |
Azido-PEG4-Val-Ala-PAB-PNP |
93 |
zyl |
2024-12-19 |
| 75506 |
NOTA-(NGR)2 NOTA偶联NGR二聚体 |
77 |
h |
2024-12-19 |
| 75507 |
1-(2,5-dioxopyrrolidin-1-yloxy)-4-((5-nitropyridin-2-yl)disulfanyl)-1-oxobutane-2-sulfonic acid，ADC定制 |
87 |
wyh |
2024-12-19 |
| 75508 |
CAS: 1343476-44-7，Val-Ala-PAB-OH |
77 |
WYQ |
2024-12-19 |
| 75509 |
MC-PBD， ADC试剂 |
86 |
kx |
2024-12-19 |
| 75510 |
Mal-Val-Ala-PAB的介绍 |
87 |
zyl |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询